News Focus
News Focus
Followers 34
Posts 6308
Boards Moderated 0
Alias Born 02/09/2015

Re: biodoc post# 208082

Wednesday, 12/13/2017 7:15:10 PM

Wednesday, December 13, 2017 7:15:10 PM

Post# of 405213
why not explore such options in a phase 3? I would imagine a pharma partner might wish to do so if that is allowed.

Or would it have to be another phase 2?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y